Succinate reverses in-vitro platelet inhibition by acetylsalicylic acid and P2Y receptor antagonists

Platelets

Volumn 23, Issue 1, 2012, Pages 60-68

  Spath, Brigitte ^a   Hansen, Arne ^a   Bokemeyer, Carsten ^a   Langer, Florian ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Acetylsalicylic acid; CD62P; P2Y1; P2Y12; Platelet aggregation; Succinate

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; G PROTEIN COUPLED RECEPTOR; PADGEM PROTEIN; PURINERGIC P2Y RECEPTOR ANTAGONIST; SUCCINIC ACID;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EXTRACELLULAR SPACE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION; TREATMENT RESPONSE;

ASPIRIN; BLOOD PLATELETS; FEMALE; HUMANS; MALE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PURINERGIC P2Y RECEPTOR AGONISTS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PURINERGIC P2Y12; SUCCINIC ACID;

EID: 83155191803     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2011.590255     Document Type: Article

References (42)

1. Depta JP, Bhatt DL. Aspirin and platelet adenosine diphosphate receptor antagonists in acute coronary syndromes and percutaneous coronary intervention: Role in therapy and strategies to overcome resistance. Am J Cardiovasc Drugs 2008;8:91-112. (Pubitemid 351596098)
2. Campbell CL, Steinhubl SR. Variability in response to aspirin: Do we understand the clinical relevance? J Thromb Haemost 2005;3:665-669. (Pubitemid 41647878)
3. Snoep JD, Hovens MM, Eikenboom JC, van der Bom JG, Jukema JW, Huisman MV. Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: A systematic review and meta-analysis. Am Heart J 2007;154:221-231. (Pubitemid 47069129)
4. Seidel H, Rahman MM, Scharf RE. Monitoring of antiplatelet therapy. Current limitations, challenges, and perspectives. Hämostaseologie 2011;31:41-51.
5. Cattaneo M. Aspirin and clopidogrel. Efficacy, safety and the issue of drug resistance. Arterioscler Thromb Vasc Biol 2002;24:1980-1987.
6. Cattaneo M. Resistance to anti-platelet agents. Thromb Res 2011;127(Suppl. 3):S61-S63.
7. Breet NJ, van Werkum JW, Bouman HJ, Kelder JC, Ruven HJ, Bal ET, Deneer VH, Harmsze AM, van der Heyden JA, Rensing BJ, et al. Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. JAMA 2010;303:754-762.
8. Mueller MR, Salat A, Stangl P, Murabito M, Pulaki S, Boehm D, Koppensteiner R, Ergun E, Mittlboeck M, Schreiner W, et al. Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty. Thromb Haemost 1997; 78:1003-1007. (Pubitemid 27417291)
9. Grundmann K, Jaschonek K, Kleine B, Dichgans J, Topka H. Aspirin non-responder status in patients with recurrent cerebral ischemic attacks. J Neurol 2003;250:63-66. (Pubitemid 36206686)
10. Von Lewinski F, Riggert J, Paulus W. Towards a rationale of platelet aggregation monitoring in stroke prophylaxis? J Stroke Cerebrovasc Dis 2009;18:111-115.
11. Bouman HJ, van Werkum JW, Breet NJ, Ten Cate H, Hackeng CM, Ten Berg JM. A case-control study on platelet reactivity in patients with coronary stent thrombosis. J Thromb Haemost 2011;9(5):909-916.
12. Patrono C. Aspirin resistance: Definition, mechanism and clinical read-outs. J Thromb Haemost 2003;1:1710-1713.
13. Ferreiro JL, Angiolillo DJ. Clopidogrel response variability: Current status and future directions. Thromb Haemost. 2009;102:7-14.
14. Angiolillo DJ, Bernardo E, Capodanno D, Vivas D, Sabaté M, Ferreiro JL, Ueno M, Jimenez-Quevedo P, Alfonso F, Bass TA, et al. Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy. J Am Coll Cardiol 2010;55:1139-1146.
15. Fong J, Cheng-Ching E, Hussain MS, Katzan I, Gupta R. Predictors of biochemical aspirin and clopidogrel resistance in patients with ischemic stroke. J Stroke Cerebrovasc Dis 2011;20(3):227-230.
16. Rubic T, Lametschwandtner G, Jost S, Hinteregger S, Kund J, Carballido-Perrig N, Schwärzler C, Junt T, Voshol H, Meingassner JG, et al. Triggering the succinatereceptor PR91 on dendritic cells enhances immunity. Nat Immunol 2008;9:1261-1269.
17. Toma I, Kang JJ, Sipos A, Vargas S, Bansal E, Hanner F, Meer E, Peti-Peterdi J. Succinate receptor GPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney. J Clin Invest 2008;118:2526-2534. (Pubitemid 351949780)
18. He W, Miao FJ, Lin DC, Schwandner RT, Wang Z, Gao J, Chen JL, Tian H, Ling L. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 2004;429:188-193. (Pubitemid 38656195)
19. Vargas SL, Toma I, Kang JJ, Meer EJ, Peti-Peterdi J. Activation of the succinate receptor GPR91 in macula densa cells causes rennin release. J Am Soc Nephrol 2009;20: 1002-1011.
20. Sapieha P, Sirinyan M, Hamel D, Zaniolo K, Joyal JS, Cho JH, Honoré JC, Kermorvant-Duchemin E, Varma DR, Tremblay S, et al. The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis. Nat Med 2008;14: 1067-1076.
21. Correa PR, Kruglov EA, Thompson M, Leite MF, Dranoff JA, Nathanson MH. Succinate is a paracrine signal for liver damage. J Hepatol 2007;47:262-269. (Pubitemid 47028584)
22. Macaulay IC, Tijssen MR, Thijssen-Timmer DC, Gusnanto A, Steward M, Burns P, Langford CF, Ellis PD, Dudbridge F, Zwaginga JJ, et al. Comparative expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins. Blood 2007;109:3260-3269. (Pubitemid 46572511)
23. Amisten S, Braun OO, Bengtsson A, Erlinge D. Gene expression profiling for the identification of G-protein coupled receptors in human platelets. Thromb Res 2008;122:47-57. (Pubitemid 351601841)
24. Hakak Y, Lehmann-Bruinsma K, Phillips S, Le T, Liaw C, Connolly DT, Behan DP. The role of the GPR91 ligand succinate in hematopoiesis. J Leukoc Biol 2009;85:837-843.
25. Hansen A, Spath B, Bokemeyer C, Eifrig B, Langer F. Identification of G protein-coupled receptors (GPCRs) in human platelets by gene expression profiling. J Thromb Haemost 2009;7:PP-MO-014.
26. Högberg C, Gidlö f O, Tan C, Svensson S, Nilsson-Ö hman J, Erlinge D, Olde B. Succinate independently stimulates full platelet activation via cAMP and phosphoinositide 3-kinase-β signaling. J Thromb Haemost 2011;9:361-372.
27. Wittenberger T, Schaller HC, Hellebrand S. An expressed sequence tag (EST) data mining strategy succeeding in the discovery of new G-protein coupled receptors. J Mol Biol 2001;307:799-813. (Pubitemid 33027660)
28. Huang EM, McGowan EB, Detwiler TC. Succinate potentiates the action of platelet agonists. Thromb Res 1984; 36:1-8. (Pubitemid 14029930)
29. Kushnir MM, Komaromy-Hiller G, Shushan B, Urry FM, Roberts WL. Analysis of dicarboxylic acids by tandem mass spectrometry. High-throughput quantitative measurement of methylmalonic acid in serum, plasma, and urine. Clin Chem 2001;47:1993-2002. (Pubitemid 33010716)
30. Krebs HA. Chemical composition of blood plasma and serum. Annu Rev Biochem 1950;19:409-430.
31. Nordmann J, Nordmann R. Organic acids in blood and urine. Adv Clin Chem 1961;4:53-120.
32. Forni LG, McKinnon W, Lord GA, Treacher DF, Peron JM, Hilton PJ. Circulating anions usually associated with the Krebs cycle in patients with metabolic acidosis. Crit Care 2005;9: R591-R595.
33. Hochachka PW, Dressendorfer RH. Succinate accumulation in man during exercise. Eur J Appl Physiol Occup Physiol 1976;35:235-242.
34. Wust J. Presumptive diagnosis of anaerobic bacteremia by gasliquid chromatography of blood cultures. J Clin Microbiol 1977;6:586-590. (Pubitemid 8252861)
35. Sanborn T, Gavin W, Berkowitz S, Perille T, Lesch M. Augmented conversion of aspartate and glutamate to succinate during anoxia in rabbit heart. Am J Physiol 1979; 237:H535-H541. (Pubitemid 10194616)
36. Taegtmeyer H. Metabolic responses to cardiac hypoxia. Increased production of succinate by rabbit papillary muscles. Circ Res 1978;43:808-815. (Pubitemid 9054875)
37. Kakinuma Y, Matsubara T, Hashimoto T, Sakamoto N. Myocardial metabolic markers of total ischemia in vitro. Nagoya J Med Sci 1994;57:35-42.
38. Smyth SS, Woulfe DS, Weitz JI, Gachet C, Conley PB, Goodman SG, Roe MT, Kuliopulos A, Moliterno DJ, French PA, et al. G-protein-coupled receptors as signaling targets for antiplatelet therapy. Arterioscler Thromb Vasc Biol 2009;29:449-457.
39. Yang J, Wu J, Jiang H, Mortensen R, Austin S, Manning DR, Woulfe D, Brass LF. Signaling through Gi family members in platelets. Redundancy and specificity in the regulation of adenylyl cyclase and other effectors. J Biol Chem 2002; 277:46035-46042. (Pubitemid 35417589)
40. Mendolicchio GL, Zavalloni D, Bacci M, Corrada E, Marconi M, Lodigiani C, Presbitero P, Rota L, Ruggeri ZM. Variable effect of P2Y12 inhibition on platelet thrombus volume in flowing blood. J Thromb Haemost. 2011;9:373-382.
41. Moscardó A, Santos MT, Fuset MP, Ruano M, Vallés J. Residual cyclooxygenase-1 activity and epinephrine reduce the antiplatelet effect of aspirin in patients with acute myocardial infarction. Thromb Haemost 2011;105(4):663-669.
42. Regard JB, Sato IT, Coughlin SR. Anatomical profiling of G protein-coupled receptor expression. Cell 2008;135:561-571.